Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/hep.26059 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Optimizing US for HCC surveillance.
Abdom Radiol (NY)
November 2024
Stanford University, Stanford, USA.
Ultrasound is the primary imaging modality used for surveillance of patients at risk for HCC. In 2017, the American College of Radiology Liver Imaging Reporting and Data Systems (ACR LI-RADS) introduced US LI-RADS to standardize the performance, interpretation, and reporting of US for HCC surveillance, with the algorithm recently updated as LI-RADS US Surveillance v2024. The American Association for the Study of Liver Diseases (AASLD) recommends reporting both the examination-level LI-RADS US Category as well as the US Visualization Score.
View Article and Find Full Text PDFIntroducing W. Ray Kim, MD, our 2024 AASLD president.
Hepatology
January 2024
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.
Clin Infect Dis
May 2023
Department of Medicine, Division of Infectious Diseases and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine.
The Infectious Diseases Society of America and the American Association for the Study of Liver Diseases have collaboratively developed evidence-based guidance regarding the diagnosis, management, and treatment of hepatitis C virus (HCV) infection since 2013. A panel of clinicians and investigators with extensive infectious diseases or hepatology expertise specific to HCV infection periodically review evidence from the field and update existing recommendations or introduce new recommendations as evidence warrants. This update focuses on changes to the guidance since the previous 2020 published update, including ongoing emphasis on recommended universal screening; management recommendations for incomplete treatment adherence; expanded eligibility for simplified chronic HCV infection treatment in adults with minimal monitoring; updated treatment and retreatment recommendations for children as young as 3 years old; management and treatment recommendations in the transplantation setting; and screening, treatment, and management recommendations for unique and key populations.
View Article and Find Full Text PDFIntroducing Norah Terrault, MD, MPH, Our 2023 AASLD President.
Hepatology
May 2023
Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
Current treatment of chronic hepatitis B: Clinical aspects and future directions.
Front Microbiol
September 2022
The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Jinhua, China.
Hepatitis B virus (HBV) infection is a public health threat worldwide, and there is no direct treatment yet available. In the event of infection, patients may present liver cirrhosis and cancer, which threaten the patients' health globally, especially in the Asia-Pacific region and China. In 2019, Chinese hepatopathologists updated the 2015 Guidelines for the Prevention and Treatment of Chronic Hepatitis B as the clinical reference.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!